Sigilon Therapeutics prices upsized IPO at $18

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Dec 4, 2020 at 11:12 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,730
    Likes Received:
    3
    via Sigilon Therapeutics (SGTX) has priced its upsized IPO of 7M common shares (from 5.6M) at $18.00/share, for expected gross proceeds of $126M.
    Underwriters' over-allotment is an additional 1.05M shares. Trading kicks off December 4.

    article source